Takeda’s Partnership with Tri-I TDI Now Encompasses Antibody Drug Discovery

June 20, 2016
Takeda Pharmaceutical has expanded the scope of a partnership with the Tri-Institutional Therapeutics Discovery Institute, a US nonprofit focusing on early-stage drug discoveries, to include antibody drug discovery from the current realm of small molecule discovery. The New York-based institute...read more